Inner Mongolia Yongbang Pharmaceutical Co., Ltd., established in August 2019 with a registered capital of 30 million RMB, is a high-tech enterprise focusing on R&D, production and sale of veterinary APIs.

The company is located in Yuanbaoshan Industrial Zone, Chifeng City, Inner Mongolia Autonomous Region, built on a total land size of 66, 667 square meters. The project is scheduled for two stages with total investment for stage one being 105 million RMB for which it was completed and put into operation in May 2021. The construction for stage one development included an office building, 2 production workshops, 2 warehouses, waste-water treatment facility and other supporting systems. With stage one workshops being fully operational, the company can achieve an annual turnover of 280 million RMB, whilst at the same time providing employment opportunities for more than 100 people.

The next stage development planning is well under way with the company looking to start Stage two in May 2023 and investing a further 145 million RMB in building five more production workshops and supporting facilities. With the completion of stage two, the company's annual turnover is expected to reach 780 million RMB, with further employment opportunities for around 360 people.

The company strictly adheres to both the international industrial standards and to the national policies and guidelines, while recognising and applying the use of our own strength and capacity to effectively grow into a dynamic and globally recognised manufacturer for veterinary APIs. We also aim to promote the development of China's veterinary API industry and to promote the development of large-scale and standardized veterinary API production. As a manufacturer of veterinary drug raw materials, the company will also devote a vast amount of emphasis on R&D in order to improve our current products and to create more varieties of vet medicine ingredients.